219 related articles for article (PubMed ID: 30785086)
1. miR-125b suppresses oral oncogenicity by targeting the anti-oxidative gene PRXL2A.
Chen YF; Wei YY; Yang CC; Liu CJ; Yeh LY; Chou CH; Chang KW; Lin SC
Redox Biol; 2019 Apr; 22():101140. PubMed ID: 30785086
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.
Chen YF; Yang CC; Kao SY; Liu CJ; Lin SC; Chang KW
Cancer Res; 2016 Aug; 76(16):4872-86. PubMed ID: 27221705
[TBL] [Abstract][Full Text] [Related]
4. miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.
Hung PS; Liu CJ; Chou CS; Kao SY; Yang CC; Chang KW; Chiu TH; Lin SC
PLoS One; 2013; 8(11):e79926. PubMed ID: 24302991
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
Li L; Ma HQ
Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis.
Chang SM; Hu WW
J Cell Physiol; 2018 Apr; 233(4):3384-3396. PubMed ID: 28926115
[TBL] [Abstract][Full Text] [Related]
7. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
[TBL] [Abstract][Full Text] [Related]
8. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-125b regulates proliferation and radioresistance of oral squamous cell carcinoma.
Shiiba M; Shinozuka K; Saito K; Fushimi K; Kasamatsu A; Ogawara K; Uzawa K; Ito H; Takiguchi Y; Tanzawa H
Br J Cancer; 2013 May; 108(9):1817-21. PubMed ID: 23591197
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
11. miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral cancer progression.
Peng SY; Tu HF; Yang CC; Wu CH; Liu CJ; Chang KW; Lin SC
Int J Cancer; 2018 Dec; 143(11):2892-2904. PubMed ID: 29971778
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of miR-455-5p by the TGF-β-SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B.
Cheng CM; Shiah SG; Huang CC; Hsiao JR; Chang JY
J Pathol; 2016 Sep; 240(1):38-49. PubMed ID: 27235675
[TBL] [Abstract][Full Text] [Related]
13. MiR-1254 Functions as a Tumor Suppressor in Oral Squamous Cell Carcinoma by Targeting CD36.
Chen R; Zhang Y; Zhang X
Technol Cancer Res Treat; 2019 Jan; 18():1533033819859447. PubMed ID: 31401948
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy.
Henson BJ; Bhattacharjee S; O'Dee DM; Feingold E; Gollin SM
Genes Chromosomes Cancer; 2009 Jul; 48(7):569-82. PubMed ID: 19396866
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-22 suppresses cell proliferation, migration and invasion in oral squamous cell carcinoma by targeting NLRP3.
Feng X; Luo Q; Wang H; Zhang H; Chen F
J Cell Physiol; 2018 Sep; 233(9):6705-6713. PubMed ID: 29319163
[TBL] [Abstract][Full Text] [Related]
16. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
17. microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1.
Wang L; Liu H
Tumour Biol; 2016 Mar; 37(3):4105-13. PubMed ID: 26490981
[TBL] [Abstract][Full Text] [Related]
18. miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma.
Du Y; Li Y; Lv H; Zhou S; Sun Z; Wang M
Int J Clin Exp Pathol; 2015; 8(10):12252-9. PubMed ID: 26722410
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
20. MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.
Guo J; Wen N; Yang S; Guan X; Cang S
Biomed Pharmacother; 2018 Aug; 104():77-86. PubMed ID: 29772443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
